Association of prostate cancer with rapidN-acetyltransferase 1 (NAT1*10) in combination with slowN-acetyltransferase 2 acetylator genotypes in a pilot case-control study

This publication has 48 references indexed in Scilit:

• Polymorphisms of Arylamine N-Acetyltransferase (NAT1 and NAT2) and Larynx Cancer Susceptibility
  ORL, 2002
• Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
  Pharmacogenetics, 2001
• Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk
  Gut, 2000
• Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue
  Carcinogenesis: Integrative Cancer Research, 2000
• Immunohistochemical Detection of Carcinogen‐DNA Adducts in Normal Human Prostate Tissues Transplanted into the Subcutis of Athymic Nude Mice: Results with 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) and 3,2′‐Dimethyl‐4‐aminobiphenyl (DMAB) and Relation to Cytochrome P450s and N‐Acetyltransferase Activity
  Japanese Journal of Cancer Research, 2000
• Arylaminc N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese
  Pharmacogenetics, 1999
• Functional polymorphism of the human arylamine JV-acetyltransferase type 1 gene caused by C190T and G560A mutations
  Pharmacogenetics, 1998
• Recent Developments in the Epidemiology of Prostate Cancer
  European Journal Of Cancer, 1997
• Dose Dependence of N‐Hydroxy‐3,2′‐dimethyM‐aminobiphenyl‐induced Rat Prostate Carcinogenesis
  Japanese Journal of Cancer Research, 1992
• Different carcinogenic responses in a variety of organs, including the prostate, of five different rat strains given 3,2′-dimethyl-4-aminobiphenyl
  Carcinogenesis: Integrative Cancer Research, 1990